Nutrition and physical activities are the most important aspects for a healthy lifestyle for a diabetic person. A high diet in fat, calories, and cholesterol increases risk of diabetes and a poor diet can lead to obesity which is the other risk factor for diabetes and other health problems. Nutrition is very important part in management of diabetes. Diabetes nutrition products are dietary products that contain less sugar and carbohydrate content. These products help in controlling blood glucose levels. Moreover, diabetes nutrition food contains low calorie diet beverages as well as sweeteners. These nutrition products are mostly consumed by diabetes patient as well non-diabetic patients as precautionary measure to prevent diabetes. These nutrition products also help to regulate other complications of diabetes such as neuropathy, nephropathy, high blood pressure along with diabetes, as these products help to maintain the lipid profile that leads to decrease in the risk of vascular complications. Diabetic patients require a low fat diet containing fruits and vegetables and low fat dairy products containing calcium, potassium, and magnesium.
Market Dynamics
Adoption of inorganic strategies, such as product approval, by regulatory authority such as the U.S. Food and Drug Administration is expected to drive the global diabetes nutrition market growth over the forecast period. For instance, in September 2022, Eli Lilly and Company, a pharmaceutical company, announced that they had received an approval from the U.S. Food and Drug Administration for Mounjaro, a tirzepatide injection treatment for Type 2 diabetes. It is the first and only FDA-approved gastric inhibitory polypeptide and glucagon-like-peptide-1 receptor agonist.
Key features of the study:
- This report provides an in-depth analysis of the global diabetes nutrition market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global diabetes nutrition market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott., Reckitt Benckiser Group PLC., Hexagonnutrition Ltd., Nestlé, Danone, Baxter, Fresenius Kabi AG, B. Braun SE, Furious Nutritions, Nature's One, Otsuka Pharmaceutical Factory, Inc., Scientific Brain Nutraceutical Pvt. Ltd., Centrum (GSK plc.), BASF SE, DSM, Zeon Lifesciences Ltd., Zenova Bio Nutrition, Nuflower Foods & Nutrition Pvt. Ltd., KD Chem Pharma, Pentasure Nutrition, Akums Drugs and Pharmaceuticals Ltd., Bionova, Zoic Pharmaceuticals., Fermentis Life Sciences, Other Prominent Players.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global diabetes nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes nutrition market
Detailed Segmentation:
- Product Type
- Standard Nutrition (Balanced macronutrient formulations)
- Disease-Specific Nutrition (Specialized for diabetes management)
- Mode of Administration
- Enteral Nutrition
- Parenteral Nutrition
- Oral Nutrition
- By Nutritional Components
- Proteins
- Carbohydrates
- Fats
- Vitamins & Minerals
- Amino Acids
- Fiber
- Others (Electrolytes, Probiotics, Phytochemicals)
- By Form
- Powder
- Liquid
- Tablets
- Soft Gels
- Others (Nutritional Gummies, Bars, etc.)
- By Patient Type
- Pediatric
- Adult
- Geriatric
- By Indication
- Prediabetic and Metabolic Syndrome
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
- Juvenile Diabetes
- By Category of Prescription
- Prescription
- Over-the-Counter (OTC)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- E-commerce
- Others (Hypermarkets, Convenience Stores, among others)
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Long Term Care Facilities
- Others (Clinics, Research centers, among others)
- By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
- Companies
- Abbott.
- Reckitt Benckiser Group PLC.
- Hexagonnutrition Ltd.
- Nestlé
- Danone
- Baxter
- Fresenius Kabi AG
- B. Braun SE
- Furious Nutritions
- Nature's One
- Otsuka Pharmaceutical Factory, Inc.
- Scientific Brain Nutraceutical Pvt. Ltd.
- Centrum (GSK plc.)
- BASF SE
- DSM
- Zeon Lifesciences Ltd.
- Zenova Bio Nutrition
- Nuflower Foods & Nutrition Pvt. Ltd.
- KD Chem Pharma
- Pentasure Nutrition
- Akums Drugs and Pharmaceuticals Ltd.
- Bionova
- Zoic Pharmaceuticals.
- Fermentis Life Sciences
- Other Prominent Players
